Provided by Tiger Fintech (Singapore) Pte. Ltd.

Lytus Technologies Holdings

0.1119
-0.0281-20.07%
Post-market: 0.11560.0037+3.31%19:59 EDT
Volume:8.55M
Turnover:989.91K
Market Cap:3.48M
PE:0.17
High:0.1296
Open:0.1293
Low:0.1037
Close:0.1400
Loading ...

Lytus Technologies Expands HealthTech Initiatives and Strengthens Growth Trajectory

GlobeNewswire
·
07 Feb

BRIEF-Lytus Technologies Pursuant To Sepa, Co Has Right To Sell Up To $100 Million Common Shares From Time To Time

Reuters
·
05 Feb

Lytus Technologies Holdings Ptv Ltd: on Feb 3, Entered Into a Standby Equity Purchase Agreement With Ya Ii Pn, Ltd

THOMSON REUTERS
·
05 Feb

Lytus Technologies: Pursuant to Sepa, Co Has Right to Sell up to $100 Million Common Shares From Time to Time

THOMSON REUTERS
·
05 Feb

Lytus Technologies Holdings PTV. Ltd. (LYT) Launches Lytus HealthTech to Enhance Healthcare Accessibility with AI-Driven Solutions

Insider Monkey
·
31 Jan

Lytus Technologies Expands Its Footprint into Healthcare with Cutting-Edge Patient-Centric HealthTech Platform

GlobeNewswire
·
28 Jan

PureTech Health Gets US FDA Fast Track Designation for LYT-200 to Treat Acute Myeloid Leukemia

MT Newswires Live
·
10 Jan

BRIEF-PureTech Health Says PRTC's LYT-200 Gets Fast Track Designation In AML

Reuters
·
09 Jan

PureTech announces receipt of FDA Fast Track Designation for LYT-200 in AML

TIPRANKS
·
09 Jan

Lytus Technologies Files for Up to $75 Million Mixed Shelf

MT Newswires Live
·
27 Dec 2024

Corrected-Lytus Technologies Holdings Ptv Ltd Files for Mixed Shelf of up to $75 Mln (Adds '$' Symbol, Removes Extraneous Words) - SEC Filing

THOMSON REUTERS
·
27 Dec 2024

BRIEF-Lytus Technologies Holdings Ptv Files For Mixed Shelf Of Up To $75 Mln-SEC Filing

Reuters
·
27 Dec 2024

Lytus Technologies files $75M mixed securities shelf

TIPRANKS
·
27 Dec 2024

NASDAQ-Listed LYTUS Appoints Visionary Leader Sai Guna Ranjan Puranam as COO (Lytus Healthcare) and Group CTO (Lytus Technologies) to Revolutionize Healthcare and Technology

PR Newswire
·
16 Dec 2024

PureTech Health presents data from dose escalation phase of LYT-200 trial

TIPRANKS
·
09 Dec 2024

Positive Outlook on PureTech Health’s LYT-100 Amid Potential Breakthrough in IPF Treatment

TIPRANKS
·
21 Nov 2024